Apple Reiterated at Outperform and 4 Reiterated Ratings Not to Miss

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on December 21st.

TIBCO Software (NASDAQ:TIBX): UBS reiterated its rating of Buy for this company and changed its price target from $32 to $30.

MasterCard (NYSE:MA): Argus reiterated its rating of Buy for this company and changed its price target from $525 to $575.

Our 20-page proprietary analysis of Apple’s stock is ready. Click here to get your Cheat Sheet report now.

Insulet (NASDAQ:PODD): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $24.5 to $29.

Apple (NASDAQ:AAPL): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $750 to $725.

Endocyte (NASDAQ:ECYT): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $12 to $15.

Don’t Miss: Apple Won’t Back Down.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business